technetium-tc-99m-sulfur-colloid and Fibrosis

technetium-tc-99m-sulfur-colloid has been researched along with Fibrosis* in 3 studies

Other Studies

3 other study(ies) available for technetium-tc-99m-sulfur-colloid and Fibrosis

ArticleYear
Scintigraphic diagnosis of pleuroperitoneal communication in cirrhosis secondary to polycythemia vera.
    Clinical nuclear medicine, 2003, Volume: 28, Issue:4

    Topics: Aged; Dyspnea; Female; Fibrosis; Humans; Peritoneovenous Shunt; Peritoneum; Pleural Effusion; Polycythemia Vera; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sulfur Colloid

2003
Radioisotope scintigraphy in the diagnosis of hepatic hydrothorax.
    Journal of gastroenterology and hepatology, 2001, Volume: 16, Issue:3

    Pleural effusion in cirrhotic patients (hepatic hydrothorax) may result from migration of ascitic fluid across defects in the diaphragm. Biochemical analysis of ascitic and pleural fluid provides only indirect information about the nature and origin of the effusion. The present study was performed in order to demonstrate the presence/absence of peritoneo-pleural communication by radioisotope imaging.. Ten patients with cirrhotic ascites and pleural effusion were studied with 99mTc sulfur colloid scintigraphy to look for movement of the radiotracer from the peritoneal to the pleural cavity. Serum-ascitic albumin gradient (SAAG) and serum-pleural fluid albumin gradient (SPAG) values were determined in eight patients to examine the nature of the ascitic and pleural fluids.. Transdiaphragmatic movement of ascitic fluid into the pleural space was demonstrated (generally within 2 h of intraperitoneal injection of the radiotracer) in eight of 10 patients; six on the right side, one on the left and one bilaterally. Two patients in whom pleural fluid was transudative on SPAG values were negative for peritoneo-pleural communications.. Radionuclide scintigraphy is a simple, safe and relatively non-invasive method to confirm passage of ascitic fluid across the diaphragm.

    Topics: Adult; Aged; Ascites; Diaphragm; Fibrosis; Humans; Male; Middle Aged; Peritoneum; Pleura; Pleural Effusion; Radionuclide Imaging; Technetium Tc 99m Sulfur Colloid

2001
Functional measurement of nonfibrotic hepatic mass in cirrhotic patients.
    The American journal of gastroenterology, 1997, Volume: 92, Issue:11

    We have postulated that the perfused hepatic mass (PHM) can be estimated by quantitative (volumetric) liver spleen scan (QLSS) using single photon emission computed tomography assessment of sulfur colloid distribution between liver, spleen, and bone marrow. Thus, this parameter should correlate with the amount of functioning tissue in the liver. As a "gold standard" estimate of the nonfibrotic functioning hepatic mass, the weight of the liver at autopsy or transplant was corrected for the amount of scar tissue present. QLSS parameters were correlated with functional hepatic mass in 13 patients with advanced liver disease with liver available at transplant (8 patients) or autopsy (5 patients) who had prior QLSS.. Greater than 1000 mm2 of a liver tissue was assessed histologically in all patients and from more than 2 regions of the liver in 9 of 13 patients. The total fibrosis score (TFS) (range, 0-17.5) was calculated as a semiquantitative estimate of hepatic fibrosis. The ratio of functioning tissue was calculated as (1 - TFS/20) and the amount of functioning tissue as the nonfibrotic weight (NFW): NFW = liver weight x (1--TFS/20). QLSS parameters were measured postprandially and 30 min after injection of 5 mCi of technetium Tc 99m sulfur colloid. Pixel and total counts from the liver, spleen, and bone marrow as well as organ length were measured. Liver/bone marrow index and liver/spleen index were calculated. The perfused hepatic mass (PHM) was defined as the mean of the liver/bone marrow index and liver/spleen index.. All patients had cirrhosis: alcoholic (1 patient), alcoholic with alcoholic hepatitis (1 patient), hepatitis B (3 patients), hepatitis C (6 patients), hepatitis C with hepatocellular carcinoma (1 patient), and primary sclerosing cholangitis (n = 1). The ratio of functioning tissue was 0.54 +/- 0.07; liver weight 1215 +/- 317 g; and NFW = 658 +/- 193 g. The PHM = 55 +/- 14. The PHM calculated from the QLSS correlated strongly with the NFW (functioning tissue) at autopsy/transplant: NFW = 13 PHM - 55; r = 0.9505; p < 0.0001).. In cirrhotic patients (a) we have confirmed that the sulfur colloid distribution by QLSS is determined by the perfused hepatic mass, and (b) the amount of functioning tissue can be precisely estimated by QLSS parameters.

    Topics: Autopsy; Biopsy; Female; Fibrosis; Humans; Liver; Liver Cirrhosis; Liver Transplantation; Male; Organ Size; Technetium Tc 99m Sulfur Colloid; Tomography, Emission-Computed, Single-Photon

1997